LU83903A1 - Quinazolines antitumorales - Google Patents

Quinazolines antitumorales Download PDF

Info

Publication number
LU83903A1
LU83903A1 LU83903A LU83903A LU83903A1 LU 83903 A1 LU83903 A1 LU 83903A1 LU 83903 A LU83903 A LU 83903A LU 83903 A LU83903 A LU 83903A LU 83903 A1 LU83903 A1 LU 83903A1
Authority
LU
Luxembourg
Prior art keywords
radical
compound
formula
ethyl
methoxy
Prior art date
Application number
LU83903A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU83903A1 publication Critical patent/LU83903A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU83903A 1981-03-06 1982-01-28 Quinazolines antitumorales LU83903A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/241,317 US4343940A (en) 1979-02-13 1981-03-06 Anti-tumor quinazoline compounds
US24131781 1981-03-06

Publications (1)

Publication Number Publication Date
LU83903A1 true LU83903A1 (fr) 1982-09-13

Family

ID=22910195

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83903A LU83903A1 (fr) 1981-03-06 1982-01-28 Quinazolines antitumorales

Country Status (31)

Country Link
US (1) US4343940A (online.php)
JP (1) JPS57158780A (online.php)
KR (1) KR880001852B1 (online.php)
AR (1) AR231138A1 (online.php)
AT (1) AT380476B (online.php)
AU (1) AU556099B2 (online.php)
BE (1) BE891936A (online.php)
CA (1) CA1163995A (online.php)
CH (1) CH647776A5 (online.php)
CY (1) CY1371A (online.php)
DE (1) DE3203770C2 (online.php)
DK (1) DK159442C (online.php)
ES (1) ES8304095A1 (online.php)
FI (1) FI71559C (online.php)
FR (1) FR2501207B1 (online.php)
GB (1) GB2094295B (online.php)
GR (1) GR75903B (online.php)
HK (1) HK4588A (online.php)
HU (1) HU189997B (online.php)
IE (1) IE52385B1 (online.php)
IL (1) IL64875A0 (online.php)
IT (1) IT1154272B (online.php)
KE (1) KE3715A (online.php)
LU (1) LU83903A1 (online.php)
NL (1) NL8200473A (online.php)
NZ (1) NZ199576A (online.php)
PH (1) PH18529A (online.php)
PT (1) PT74394B (online.php)
SE (1) SE461732B (online.php)
SG (1) SG30787G (online.php)
YU (1) YU42031B (online.php)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3131365A1 (de) * 1981-08-07 1983-02-24 Henkel KGaA, 4000 Düsseldorf Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit
US4963554A (en) * 1990-02-14 1990-10-16 Ortho Pharmaceutical Corporation 6,7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides
US5030635A (en) * 1990-02-14 1991-07-09 Ortho Pharmaceutical Corporation 6-7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides
US5710158A (en) * 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
USRE37650E1 (en) 1991-05-10 2002-04-09 Aventis Pharmacetical Products, Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
US6645969B1 (en) * 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5714493A (en) * 1991-05-10 1998-02-03 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
EP0634169B1 (en) * 1993-06-29 2000-01-05 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis
PL315941A1 (en) * 1994-02-23 1996-12-09 Pfizer 4-heterocyclic substituted derivatives of quinazoline, methods of obtaining them and their application as anticarcinogenic agents
US5804396A (en) * 1994-10-12 1998-09-08 Sugen, Inc. Assay for agents active in proliferative disorders
TW321649B (online.php) * 1994-11-12 1997-12-01 Zeneca Ltd
GB9424233D0 (en) * 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
US5837524A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polynucleotide products
GB9508537D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
GB9508535D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivative
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
EP0824525B1 (en) * 1995-04-27 2001-06-13 AstraZeneca AB Quinazoline derivatives
DE69618587T2 (de) * 1995-06-07 2002-08-29 Sugen, Inc. Chinazoline und pharmazeutische zusammensetzungen
WO1997017329A1 (en) * 1995-11-07 1997-05-15 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
US7119174B2 (en) * 1995-12-18 2006-10-10 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
US6716575B2 (en) 1995-12-18 2004-04-06 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
WO1997030035A1 (en) 1996-02-13 1997-08-21 Zeneca Limited Quinazoline derivatives as vegf inhibitors
GB9603097D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline compounds
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
ES2169355T3 (es) 1996-03-05 2002-07-01 Astrazeneca Ab Derivados de 4-anilinoquinazolina.
GB9607729D0 (en) * 1996-04-13 1996-06-19 Zeneca Ltd Quinazoline derivatives
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
JP2001505779A (ja) * 1996-12-11 2001-05-08 スージェン・インコーポレーテッド Ｐｙｋ２関連産物および方法
US6818440B2 (en) * 1997-04-28 2004-11-16 Sugen, Inc. Diagnosis and treatment of alk-7 related disorders
US6228641B1 (en) 1997-05-20 2001-05-08 Sugen, Inc. Diagnosis and treatment of PTP04 related disorders
US6342593B1 (en) 1997-06-11 2002-01-29 Sugen, Inc. Diagnosis and treatment of ALP related disorders
US7115710B2 (en) * 1997-06-11 2006-10-03 Sugen, Inc. Diagnosis and treatment of PTP related disorders
US6388063B1 (en) 1997-06-18 2002-05-14 Sugen, Inc. Diagnosis and treatment of SAD related disorders
US6495353B1 (en) 1998-01-21 2002-12-17 Sugen, Inc. Human orthologues of wart
AU3642499A (en) 1998-04-14 1999-11-01 Sugen, Inc. Ste20-related protein kinases
AU4317399A (en) 1998-05-28 1999-12-13 Parker Hughes Institute Quinazolines for treating brain tumor
US6800649B1 (en) 1998-06-30 2004-10-05 Parker Hughes Institute Method for inhibiting c-jun expression using JAK-3 inhibitors
EP1105378B1 (en) * 1998-08-21 2005-03-30 Parker Hughes Institute Quinazoline derivatives
US6861442B1 (en) 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
US6080747A (en) 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
US6258820B1 (en) 1999-03-19 2001-07-10 Parker Hughes Institute Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
US20030162223A1 (en) * 1999-10-22 2003-08-28 Lowery David E. Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
WO2001031005A2 (en) * 1999-10-22 2001-05-03 Pharmacia & Upjohn Company Drosophila g protein coupled receptors, nucleic acids, and methods related to the same
US7364866B2 (en) * 1999-10-22 2008-04-29 Pharmacia & Upjohn Company Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
CN100376567C (zh) 1999-11-05 2008-03-26 阿斯特拉曾尼卡有限公司 作为vegf抑制剂的喹唑啉衍生物
CA2388865A1 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
US20030082534A1 (en) * 1999-11-16 2003-05-01 Peter Lind Novel G protein-coupled receptors
WO2001062797A2 (en) * 2000-02-23 2001-08-30 Pharmacia & Upjohn Company G protein-coupled receptors
US7160889B2 (en) * 2000-04-07 2007-01-09 Astrazeneca Ab Quinazoline compounds
US20050069976A1 (en) * 2001-02-14 2005-03-31 Peter Lind Protein-coupled receptor
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
DE60316810T2 (de) 2002-08-02 2008-07-17 Ab Science 2-(3-aminoaryl)amino-4-aryl-thiazole und ihre verwendung als c-kit inhibitoren
PL1684750T3 (pl) * 2003-10-23 2010-10-29 Ab Science 2-Aminoarylooksazole jako inhibitory kinazy tyrozynowej
EP2361624A1 (en) 2005-04-04 2011-08-31 AB Science Oxazole derivatives and their use as tyrosine kinase inhibitors
US8246966B2 (en) * 2006-08-07 2012-08-21 University Of Georgia Research Foundation, Inc. Trypanosome microsome system and uses thereof
CA2663436A1 (en) 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
WO2008066755A2 (en) 2006-11-22 2008-06-05 University Of Georgia Research Foundation, Inc. Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents
SG177225A1 (en) * 2006-12-01 2012-01-30 Agency Science Tech & Res Cancer-related protein kinases
KR102061743B1 (ko) 2011-03-04 2020-01-03 뉴젠 세러퓨틱스 인코포레이티드 알킨 치환된 퀴나졸린 화합물 및 그것의 사용 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3298291A (en) * 1965-12-28 1967-01-17 Jack D Layton Paver screed assembly
US3455920A (en) * 1967-01-13 1969-07-15 Squibb & Sons Inc 2,3-dihydro-5 and 6-substituted-2-phenyl-4(1h)-quinazolinones
US3637693A (en) * 1968-07-12 1972-01-25 Du Pont Hydroxyarylquinazolines and their use as uv-absorbers
DE2050092C3 (de) 1970-10-13 1980-04-24 Bayer Ag, 5090 Leverkusen Chinazolondiurethane, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten
AU438472B2 (en) * 1970-12-23 1973-08-09 Sumitomo Chemical Company, Limited Quinazolinone derivatives anda process for production thereof
JPS6011032B2 (ja) 1975-12-16 1985-03-22 大鵬薬品工業株式会社 ２―置換―５―フルオルピリミジン―４―オン誘導体の製造法
US4080455A (en) * 1975-12-16 1978-03-21 Taisho Pharmaceutical Company Limited 5-Fluoropyrimidin-4-one compositions

Also Published As

Publication number Publication date
YU42031B (en) 1988-04-30
GR75903B (online.php) 1984-08-02
FR2501207A1 (fr) 1982-09-10
FR2501207B1 (fr) 1985-12-06
JPS57158780A (en) 1982-09-30
IL64875A0 (en) 1982-03-31
DE3203770C2 (de) 1993-11-04
DE3203770A1 (de) 1982-11-11
ATA39582A (de) 1985-10-15
KR880001852B1 (ko) 1988-09-22
SE461732B (sv) 1990-03-19
FI71559C (fi) 1987-01-19
CH647776A5 (de) 1985-02-15
ES509434A0 (es) 1983-02-16
IE820163L (en) 1982-09-06
JPH0337552B2 (online.php) 1991-06-05
GB2094295A (en) 1982-09-15
BE891936A (fr) 1982-07-28
PT74394A (en) 1982-03-01
FI820399L (fi) 1982-09-07
CA1163995A (en) 1984-03-20
NZ199576A (en) 1986-05-09
NL8200473A (nl) 1982-10-01
IT8247713A0 (it) 1982-02-03
KR830009050A (ko) 1983-12-17
ES8304095A1 (es) 1983-02-16
FI71559B (fi) 1986-10-10
HU189997B (en) 1986-08-28
CY1371A (en) 1987-08-07
KE3715A (en) 1987-04-16
SE8200526L (sv) 1982-09-07
PH18529A (en) 1985-08-02
DK50482A (da) 1982-09-07
GB2094295B (en) 1984-09-12
AU7998182A (en) 1982-09-09
PT74394B (en) 1984-10-22
SG30787G (en) 1988-09-16
US4343940A (en) 1982-08-10
IE52385B1 (en) 1987-10-14
AR231138A1 (es) 1984-09-28
IT1154272B (it) 1987-01-21
DK159442B (da) 1990-10-15
DK159442C (da) 1991-03-18
AT380476B (de) 1986-05-26
HK4588A (en) 1988-01-29
YU25682A (en) 1985-03-20
AU556099B2 (en) 1986-10-23
IT8247713A1 (it) 1983-08-03

Similar Documents

Publication Publication Date Title
FR2501207A1 (fr) Composes quinazoliniques antitumoraux et leur procede de production
EP0010029B1 (fr) Ellipticines substituées en position 1 par une chaîne polyaminée, leur synthèse et médicaments les contenant
FR2577551A1 (fr) Derives de benzoyl uree, procede pour les preparer, et compositions antitumorales les contenant
JPH05508619A (ja) ヒト結腸直腸癌の有効な抑制剤であるカンプトセシンアナローグ
FI74002C (fi) Foerfarande foer framstaellning av - karbolinderivat.
CH633796A5 (fr) Dipyridoindoles therapeutiquement actifs.
EP0446141B1 (fr) Nouveaux dérivés d'imidazo [1,2-C] quinazoline leur procédé de préparation et les compositions pharmaceutiques les renfermant
BE1000573A4 (fr) Derives de 1-(hydroxystyryl)-5h-2,3-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant.
FR2647676A1 (fr) Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
MC1969A1 (fr) Procedes pour preparer des composes antitumoraux,formulation pharmaceutique contenant ces composes,leurs utilisations en medecine et pharmacie,et composes intermediaires pour leur preparation
GB2173195A (en) Pharmaceutical compositions
EP0187085B1 (fr) Dérivés 1-substitués de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoléine-3-carboxylique, leur préparation et leur application en tant que médicaments
CA1204442A (fr) Procede de preparation de nouveaux derives de la nitrosouree
HU197746B (en) Process for producing xantin derivatives and pharmaceutical compositions containing them
MC1186A1 (fr) Derives de quinazoline
BE897208A (fr) Composes de carbostyryle
CN106243130A (zh) 3,6‑二芳基‑[1,2,4]三氮唑并[3,4‑b][1,3,4]噻二嗪类化合物及其用途
EP0711767A1 (en) Antineoplastic cyclolignan derivatives
EP1476426A2 (en) Hydroxylated indirubin derivatives
JPS625160B2 (online.php)
JPH09176166A (ja) ビス−アザ−二環式抗不安薬の製法
Sliwa et al. Synthèse et étude structurale d'alcoxy‐8 et hydroxy‐8 [1, 2, 4] triazolo [4, 3‐c] et [1, 5‐c] pyrimidines
FR2653430A1 (fr) Nouveaux derives de dihydro-1,2 oxo-2 quinoxalines, leur preparation et leur application en therapeutique.
FR2676733A1 (fr) Derives de phenyl-1 dihydro-1,4 hydroxy-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique.
KR100221999B1 (ko) 신규한 트리아졸로피리미딘 유도체와 이의 제조방법